BioCertica is a listed health-sciences and AI-driven ventures platform building, acquiring and scaling science-led businesses across genomics, diagnostics, longevity, biotechnology, preventive health and applied health intelligence.
BioCertica is being built as the listed entity through which a focused group of health-science and AI-driven ventures can be owned, operated and scaled. The group combines operating discipline, scientific credibility, applied health intelligence and public-market access to compound value across consumer health, diagnostics, biotechnology, data, AI and longevity.
We run our core brands as operators, not passive investors. eightygood is the flagship consumer and practitioner-facing brand, bringing DNA testing, biomarkers, wearables and personalised health insights into one preventive-health platform.
We look for science-led businesses, IP, products and distribution channels that can become stronger inside the BioCertica platform. The strategy is to bring fragmented health-science, longevity, biotech and AI-enabled ventures into one governed, data-driven listed group.
We scale through shared infrastructure: genomics, clinical partnerships, practitioner enablement, data systems, AI agents, compliance, capital allocation and transparent reporting to shareholders.
From consumer genomics to clinical diagnostics, biotechnology and AI-enabled health infrastructure, each company in the BioCertica group is selected for scientific relevance, commercial scalability and strategic fit.
BioCertica's flagship direct-to-consumer brand. DNA and blood-biomarker testing, wearables and lifestyle data unified into one longevity platform, with personalised, science-driven health reports.
Visit eightygood.comStrategic biotechnology exposure centred on PR33, a science-led compound being explored for traumatic brain injury, neuroprotection and brain-health recovery. It adds a therapeutic-IP layer to the group, connecting high-potential compounds with BioCertica's clinical partnerships, data capture and long-term evidence generation.
Deal-in-progress platform giving employers a practical way to support workforce wellbeing — digital assessments, personalised health journeys, wearable integration and AI-driven engagement. For BioCertica it opens a scalable B2B channel into preventive testing, genomics and coaching, generating consent-based population-health insight over time.
Deal-stage insurtech opportunity built on behaviour-based insurance linked to preventive health, wellness engagement and biomarker improvement. It connects BioCertica's genomics, wearable and AI risk-intelligence to insurers and employer groups, rewarding healthier behaviour and moving partners from static underwriting to continuous, data-informed risk.
BioCertica's market data, filings and disclosure are published and maintained on OTC Markets under ticker HTHL. Live information is linked directly below.
BioCertica is pursuing its public listing via an OTC Markets-quoted vehicle (ticker HTHL). Market data, filings and disclosure are hosted and maintained on OTC Markets.
Investor enquiries: investors@biocertica.ai
Architects the scientific frameworks that turn complex genetic data into actionable health insights, spanning NGS and statistical genetics, bioinformatics engineering and machine-learning integration.
A world-class expert in brain health, guiding the therapeutic roadmap, clinical positioning and regulatory standards behind the group's science-backed offerings.
Provides strategic leadership for the group, driving growth, innovation, partnerships and long-term organisational success.
Supports the CEO through strategic planning, project coordination and cross-functional execution across key business initiatives.
Oversees financial strategy, governance, budgeting and risk management to support sustainable business growth.
Manages genetic test production, logistics, warehousing and operational delivery across the MEA and Asia regions.
Leads global distribution, laboratory operations, pricing strategy and genetic-results pipelines for scalable delivery.
Drives global sales growth and therapeutics innovation through strategic partnerships and new product pipelines.
Oversees therapeutics production, supplier partnerships, regulatory compliance and research collaborations across LATAM and North America.
Directs marketing, brand strategy and social-media initiatives to drive engagement, awareness and commercial growth.
Manages customer service and stakeholder relationships while supporting outreach programmes for schools and practitioners.
Supports day-to-day financial operations, administration and reporting across the group.
Supports financial operations, administration and reporting to ensure efficient financial management.
Supports regulatory compliance and market expansion, ensuring adherence to regional standards and operational requirements.
Played a fundamental role in establishing and growing the group, providing strategic support in automation, technology and AI-driven innovation.
Provides strategic investment support and high-level business advisory guidance to drive long-term growth and expansion.
Supports the group through key investment involvement and commercial advisory input, contributing industry insight and strategic direction.
Leads investor and partnership engagement, building strategic relationships and supporting growth and expansion initiatives.
Supports investor relations and strategic partnerships, with a focus on growth opportunities in the UAE region.
Identifies potential investors and builds strategic relationships to strengthen the group's presence and funding opportunities in Canada.
Brings extensive industry expertise and strategic advisory insight to support the group's growth and long-term direction.
Join our investor mailing list for results, SENS announcements and portfolio updates.
Contact investor relations
BioCertica